A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : anti-PD-1

Search Conditions:
Search Keyword : anti-PD-1
Search Method : Exact match.
Research Area:

Abbreviation: anti-PD-1
Appearance Frequency: 133 time(s)
Long forms: 13

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
anti-programmed cell death protein 1
(44 times)
(22 times)
PFS (6 times)
anti-PD-L1 (5 times)
CI (5 times)
2016 Biomarkers for immunotherapy in genitourinary malignancies.
anti-programmed cell death-1
(42 times)
(17 times)
anti-PD-L1 (5 times)
NSCLC (5 times)
OS (4 times)
2013 What lies within: novel strategies in immunotherapy for non-small cell lung cancer.
anti-programmed death-1
(28 times)
(17 times)
NSCLC (7 times)
anti-PD-L1 (6 times)
irAEs (3 times)
2015 Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges.
anti-programmed cell death receptor-1
(10 times)
(3 times)
anti-BTLA (1 time)
anti-PD-L1 (1 time)
cDNA (1 time)
2014 The new normal: immunomodulatory agents against sepsis immune suppression.
anti-programmed death molecule 1
(1 time)
--- 2019 Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment.
anti-tumor immunity, anti-program death 1
(1 time)
(1 time)
AA (1 time)
ICP (1 time)
TKI (1 time)
antibodies blocking programmed cell death protein 1 receptor
(1 time)
(1 time)
ORR (1 time)
2020 Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma.
Antibodies blocking programmed death 1
(1 time)
Breast Neoplasms
(1 time)
--- 2019 Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
antibodies that block the programmed death-1
(1 time)
(1 time)
CTLA-4 (1 time)
T-VEC (1 time)
2019 Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma.
10  antibodies to programmed cell death-1 receptor
(1 time)
Diabetes Mellitus
(1 time)
--- 2018 New-onset insulin-dependent diabetes due to nivolumab.
11  antibody blockade of the inhibitory receptor PD-1
(1 time)
Allergy and Immunology
(1 time)
TILs (1 time)
2019 Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
12  antibody to the programmed death-1 protein
(1 time)
(1 time)
ASCproject (1 time)
HNFS (1 time)
TMB (1 time)
2020 The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
13  antiprogrammed death inhibitor-1
(1 time)
Genetics, Medical
(1 time)
TGF-beta (1 time)
2019 An Oncolytic Adenovirus Targeting Transforming Growth Factor beta Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.